What MyTherapy does

MyTherapy is a medication management and adherence platform developed by smartpatient, a digital health subsidiary of Redcare Pharmacy (formerly Shop Apotheke), headquartered in Munich, Germany. The platform serves over 12 million patients globally across 16+ language versions, providing reliable medication reminders, automatic intake documentation, refill alerts, symptom and measurement tracking (blood pressure, blood sugar, weight, mood), and printable health reports shareable with physicians via a one-time code mechanism. A complementary web-based dashboard, MyTherapy Professional, enables doctors, pharmacists, and nurses to monitor patient adherence between visits.

The technical stack centers on a mobile health application for iOS and Android, augmented in March 2025 by Mighty, an AI-powered conversational health assistant that has facilitated over 50,000 patient interactions with 47% classified as health-related queries. The platform also includes a medication reference database (DrugWiki/FarmaWiki) and, as of March 2026, integration with arztkonsultation's telemedicine infrastructure to deliver an integrated digital care pathway initially targeting clinical obesity. Clinical credibility is supported by a Charité Berlin study showing an 89% on-time medication intake rate among Type 2 diabetes participants using the app.

MyTherapy operates a freemium, product-led business model: the app is permanently free for patients with no advertising, while revenue is generated through partnerships with pharmaceutical companies and healthcare institutes that require aggregated medication adherence data, plus Direct-to-Patient program infrastructure sold to pharma clients. Distribution is primarily via iOS App Store and Google Play, supplemented by content marketing, social media, earned media (Wired, ABC, Healthline), and healthcare professional referrals through the Professional dashboard. Co-founders Julian Weddige, Philipp Legge, and Sebastian Gaede (managing director) lead the smartparent entity, which operates without disclosed external venture funding.

Name

MyTherapy

Legal name

smartpatient

Website

https://mytherapyapp.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

MyTherapy, developed by smartpatient (a Redcare Pharmacy subsidiary), is a free medication management app serving 12+ million patients globally with reminders, intake tracking, symptom logging, and doctor report sharing. Revenue is generated through pharmaceutical partnerships and Direct-to-Patient program infrastructure rather than patient fees.

Ownership category

akta.pro rank

Product category

Medication Management Software

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Offices of Physicians (6211)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)

akta.pro secondary industries

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Remote Adherence Monitoring & Smart Dispenser Services (HSABALAI), Healthcare & Wellness Personalization (HDAAAGAI)

Keywords

• Medication management app
• Digital health companion
• Patient adherence platform
• Chronic disease tracking
• Direct-to-patient programs

Headquarters

HQ city

Nederland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Pharmaceutical Partnership Model: MyTherapy remains completely free for patients while generating revenue through partnerships with pharmaceutical companies and healthcare institutes who value medication adherence information. The company cooperates with partners to whom medication adherence data is vital, without sharing personal user data with these partners.
2. Direct-to-Patient Program Infrastructure: MyTherapy positions itself as digital infrastructure for scalable Direct-to-Patient programs targeting pharmaceutical partners, enabling clinical programs and patient engagement at scale.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

MyTherapy is a mobile medication management and adherence platform that delivers reliable medication reminders, automatic intake documentation, symptom and measurement tracking, refill alerts, and a doctor-shareable health report for individual patients. The consumer app is offered free of charge across 16+ languages and is complemented by a separate professional web dashboard for healthcare providers and Direct-to-Patient program infrastructure sold to pharmaceutical partners. Revenue is generated through pharmaceutical partnerships and B2B program engagements while the patient experience remains ad-free.

Product overview

MyTherapy is a single unified mobile application (iOS and Android) offering a comprehensive medication management and digital health companion platform. The core MyTherapy App delivers medication reminders, intake documentation, symptom tracking, and health reports to patients. MyTherapy Professional extends the platform with a web-based dashboard for healthcare providers to monitor patient adherence. Mighty is an AI-powered conversational assistant integrated into the app, supporting over 12 million patients globally. The product also includes a medication database (DrugWiki/FarmaWiki). The company positions MyTherapy as digital infrastructure for Direct-to-Patient programs for pharmaceutical industry engagement.

Differentiator

Problem solved

Functional benefit

Products and services

• MyTherapy App

Quantifiable outcome

• 89% of study participants correctly took their medication while using MyTherapy (Charité Berlin research on Type 2 diabetes patients)
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• arztkonsultationcoreStrategic or Co-development Partner · 5 March 2026Strategic partnership to establish an integrated digital care pathway launching initially in clinical obesity. The collaboration combines MyTherapy's patient activation and medication management platform with arztkonsultation's telemedicine infrastructure to address fragmented care pathways, reduce time-to-diagnosis, shorten specialist waiting times, and improve medication adherence.
• Charité BerlinminorOthersResearch partnership with Charité Berlin Universitätsmedizin for clinical studies on medication adherence. Research conducted by Charité's Geriatrics Research Group on Type 2 diabetes patients showed 89% adherence rate among MyTherapy users.
• Shop Apotheke (Redcare Pharmacy)minorChannel Partner/ Reseller/ DistributorShop Apotheke (now Redcare Pharmacy) is displayed as a partner on MyTherapy's website. The partnership appears to involve distribution and promotional support for the medication management platform.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Medisafe: Medisafe is a direct competitor offering a personalized medication management platform with reminders, adherence tracking, and pharma partnerships. Both companies compete head-to-head in the consumer medication adherence app category serving chronic disease patients globally.
• Mango Health: Mango Health is a medication adherence and chronic condition management app that similarly combines reminders, health tracking, and incentives. It operates with a comparable freemium model and partners with pharma and payers to monetize adherence data.
• CareZone: CareZone provides medication management, refill coordination, and health journaling for patients and caregivers. It shares MyTherapy's core feature set of medication reminders, symptom tracking, and care team coordination in the consumer health space.
• Voluntis: Voluntis (now part of AptarGroup) develops digital therapeutics and connected drug delivery companion apps for pharma. It directly competes with MyTherapy's pharma partnership business model, providing software co-prescribed with medications.
• Propeller Health: Propeller Health (ResMed) provides connected inhaler medication adherence solutions for respiratory patients. It shares MyTherapy's focus on medication adherence data generation for pharma partners, though specialized to inhaled therapies.

Emerging players

• Ada Health: Ada Health operates a symptom assessment and AI health assistant platform comparable to MyTherapy's Mighty AI. Both are European-headquartered health AI companies leveraging conversational interfaces for patient engagement and pharma partnerships.
• Kaia Health: Kaia Health is a digital therapeutics company for chronic pain and COPD with AI-driven coaching. It shares MyTherapy's D2P pharma partnership model and consumer-facing adherence/coaching approach, though focused on musculoskeletal and respiratory conditions.

Others

• Redcare Pharmacy: Redcare Pharmacy is the publicly-listed parent company of smartpatient (MyTherapy's operator). It is a major European online pharmacy providing direct distribution and strategic alignment, though it operates in pharmacy retail rather than adherence software.

Broad incumbents

• Omada Health: Omada Health is a digital chronic care platform offering condition-specific programs (diabetes, hypertension) with coaching and connected devices. It overlaps with MyTherapy in chronic disease adherence and digital therapeutics though at a higher acuity and price point.
• Tunstall Healthcare: Tunstall Healthcare is an established UK/EU remote patient monitoring and telehealth provider serving chronic disease patients and care providers. It overlaps with MyTherapy's RPM and adherence positioning though primarily via hardware and clinician platforms rather than consumer apps.

Market position

Strengths5 records

Weaknesses2 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/mytherapy_app
• Facebookfacebook.com/mytherapyapp

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MyTherapy